EFFECTS OF A MODIFIED CMF TREATMENT (CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL) ON HEMATOPOIETIC TISSUES AND YOSHIDA SARCOMA IN RATS

Citation
K. Savovski et al., EFFECTS OF A MODIFIED CMF TREATMENT (CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL) ON HEMATOPOIETIC TISSUES AND YOSHIDA SARCOMA IN RATS, Acta oncologica, 33(7), 1994, pp. 793-798
Citations number
19
Categorie Soggetti
Oncology
Journal title
ISSN journal
0284186X
Volume
33
Issue
7
Year of publication
1994
Pages
793 - 798
Database
ISI
SICI code
0284-186X(1994)33:7<793:EOAMCT>2.0.ZU;2-I
Abstract
Effects of a modified CMF treatment on hematopoietic tissue and an imp lanted tumor were studied in rats. The modification of the treatment r efers to the application of cyclophosphamide 24 h after methotrexate a nd 5-fluorouracil. The study was done on Wistar rats bearing Yoshida s arcoma in the ascites form. The controls were a) untreated animals bea ring the tumor or b) treated conventionally with the 3 cytostatics and c) tumor-free animals under either conventional treatment or d) modif ied treatment. We examined survival, the appearance of metastases, and the regeneration of hematopoietic tissues. Improved survival, the abs ence of metastases, and improved regeneration of hematopoietic tissues was observed when modified CMF treatment was applied. These results s upport the importance of sequencing cytostatic protocols for basic hem atological determinants and anti-tumor activity.